Showing results (81-90 of 1,337) with videos related to

Sort By:
Pageof 134
Neuro-Oncology Advances|November 5, 2021
Comparative evaluation of T-cell receptors in experimental glioma-draining lymph nodesJens Blobner, Michael Kilian, Chin Leng Tan, et al.
Neuro-Oncology Advances|December 3, 2021
Targeted therapy strategies for melanoma brain metastasisChantal Saberian, Paul Sperduto, Michael A Davies
Neuro-Oncology Advances|January 6, 2022
Reevaluating surgery and re-irradiation for locally recurrent pediatric ependymoma-a multi-institutional studyDavid Y Mak, Normand Laperriere, Vijay Ramaswamy, et al.
Neuro-Oncology Advances|October 27, 2022
Germline polymorphisms in MGMT associated with temozolomide-related myelotoxicity risk in patients with glioblastoma treated on NRG Oncology/RTOG 0825Michael E Scheurer, Renke Zhou, Mark R Gilbert, et al.
Neuro-Oncology Advances|October 27, 2022
PD-L1 expression in breast cancer brain metastasesRania Chehade, Maleeha A Qazi, Marguerite Ennis, et al.
Neuro-Oncology Advances|October 27, 2022
Protein arginine methyltransferase 5 regulates SHH-subgroup medulloblastoma progressionDaniel T Wynn, Jezabel Rodriguez-Blanco, Jun Long, et al.
Neuro-Oncology Advances|November 3, 2022
Factors affecting the radiation response in glioblastomaRadhika Aiyappa-Maudsley, Anthony J Chalmers, Jason L Parsons
Neuro-Oncology Advances|October 17, 2022
Determinants of tumor treating field usage in patients with primary glioblastoma: A single institutional experienceMatthew T Ballo, Kaitlin W Qualls, L Madison Michael, et al.
Neuro-Oncology Advances|September 15, 2022
Systematic review of diffuse hemispheric glioma, H3 G34-mutant: Outcomes and associated clinical factorsCameron Crowell, Daddy Mata-Mbemba, Julie Bennett, et al.
Neuro-Oncology Advances|September 15, 2022
An investigation of the conformity, feasibility, and expected clinical benefits of multiparametric MRI-guided dose painting radiotherapy in glioblastomaCaterina Brighi, Paul J Keall, Lois C Holloway, et al.
Pageof 134